Literature DB >> 2008801

Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB).

M Page1, K H Mills, G C Schild, C Ling, V Patel, A McKnight, A L Barnard, P Dilger, R Thorpe.   

Abstract

Recombinant DNA-derived gp120 (HIV-1IIIB) expressed in chinese hamster ovary cells elicited specific humoral and cell-mediated immune responses in a variety of mammals. Antisera from immunized rabbits, sheep and goats recognized virus-derived gp120 and its precursor (gp160). Neutralizing antibodies were also elicited, but only in a few animals, and this may be related to the protein's susceptibility to cleavage through the neutralizing domain. However, in rabbits the degree of cleavage of gp120 had little or no effect on its antigenicity or immunogenicity. All antisera had limited cross-reactivity to envelope glycoproteins from a panel of HIV-1 isolates suggesting that immunodominant antibody epitopes are in variable regions of the recombinant gp120. Antigen-specific T-cell responses were detected in immunized macaques and were found to be stronger and more prolonged when gp120 was administered in Freund's adjuvant rather than alum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008801     DOI: 10.1016/0264-410x(91)90316-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

Authors:  U K von Schwedler; T L Stemmler; V Y Klishko; S Li; K H Albertine; D R Davis; W I Sundquist
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

2.  Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.

Authors:  Joseph P Nkolola; Hanqin Peng; Ethan C Settembre; Michael Freeman; Lauren E Grandpre; Colleen Devoy; Diana M Lynch; Annalena La Porte; Nathaniel L Simmons; Ritu Bradley; David C Montefiori; Michael S Seaman; Bing Chen; Dan H Barouch
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

3.  Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation.

Authors:  Martin P Cranage; Carol A Fraser; Alethea Cope; Paul F McKay; Michael S Seaman; Tom Cole; A Nasir Mahmoud; Joanna Hall; Elaine Giles; Gerald Voss; Mark Page; Neil Almond; Robin J Shattock
Journal:  Vaccine       Date:  2010-12-25       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.